Part I Prescriptions
Where a limitation or a route of administration is indicated with respect to a drug listed in Schedule 1, either in a sub-category heading or with respect to that particular drug, a member shall only prescribe the drug in compliance with the limitation and in accordance with the route of administration specified.
No member may prescribe any drug unless he or she has successfully completed the relevant training in pharmacology that has been approved by the Council.
Every time a member prescribes a drug the member shall record the following in the patient’s health record as that record is required to be kept under section 10 of Ontario Regulation 119/94 (General) made under the Act:
Details of the prescription, including the drug prescribed, dosage and route of administration.
Details of the counselling provided by the member to or on behalf of the patient respecting the use of the drug prescribed.
In the course of engaging in the practice of optometry a member may prescribe any drug that may lawfully be purchased or acquired without a prescription.
Part II Standards of Practice — Glaucoma
It is a standard of practice of the profession that in treating glaucoma a member may only prescribe a drug set out under the category of “Antiglaucoma Agents” in Schedule 1.
(1) Subject to subsection (2) and to section 8, it is a standard of practice of the profession that a member may only treat a patient with glaucoma where the patient has primary open-angle glaucoma the treatment of which is not complicated by either a concurrent medical condition or a potentially interacting pharmacological treatment.
It is a standard of practice of the profession that a member may only treat a patient having open-angle glaucoma, the treatment of which is complicated by either a concurrent medical condition or a potentially interacting pharmacological treatment, in collaboration with a physician with whom the member has established a co-management model of care for that patient and who is,
certified by the Royal College of Physicians and Surgeons of Canada as a specialist in ophthalmology; or
formally recognized in writing by the College of Physicians and Surgeons of Ontario as a specialist in ophthalmology.
It is a standard of practice of the profession that a member may initiate treatment for a patient having angle-closure glaucoma only in an emergency and where no physician is available to treat the patient.
It is a standard of practice of the profession that a member shall immediately refer any patient being treated in accordance with subsection (2) to a physician or hospital once the emergency no longer exists or once a physician becomes available, whichever comes first.
In this section,
“hospital” means a hospital within the meaning of the Public Hospitals Act.
Omitted (provides for coming into force of provisions of this Regulation).
SCHEDULE 1
Antibacterials (topical)
azithromycin
besifloxacin
ciprofloxacin
erythromycin
framycetin
fusidic acid
gatifloxacin
gentamicin
moxifloxacin
ofloxacin
polymyxin B/gramicidin/neomycin
polymyxin B/neomycin/ bacitracin
polymyxin B/trimethoprim
sulfacetamide
tetracycline
tobramycin
Antifungals (topical)
natamycin
Antivirals (topical)
trifluridine
Acyclovir
Antibacterials (oral) – for corneal or eyelid infections only and for a duration not exceeding 14 days
amoxicillin
amoxicillin/clavulanic acid
azithromycin
cephalexin
ciprofloxacin
clarithromycin
clindamycin
cloxacillin
doxycycline
erythromycin
levofloxacin
minocycline
moxifloxacin
tetracycline
Antivirals (oral) – for corneal or eyelid infections only
acyclovir
famciclovir
valacyclovir
Corticosteroids (topical)
dexamethasone
difluprednate
fluorometholone
loteprednol
prednisolone
rimexolone
Corticosteroids (topical) – for the purpose of treating conditions of the eye and adnexa
triamcinolone
Immunomodulators (topical)
cyclosporine
Nonsteroidal anti-inflammatory agents (topical)
bromfenac
diclofenac
ketorolac
nepafenac
Antibacterials /corticosteroids (topical)
framycetin/gramicidin/dexamethasone
gentamicin/betamethasone
neomycin/fluorometholone
neomycin/polymyxin B/dexamethasone
neomycin/bacitracin/polymyxin B/hydrocortisone
sulfacetamide/prednisolone
tobramycin/dexamethasone
Mydriatics (topical)
atropine
cyclopentolate
homatropine
tropicamide
Antiallergic agents (topical)
bepotastine
emedastine
ketotifen
levocabastine
lodoxamide
nedocromil
olopatadine
tacrolimus – for the purpose of treating conditions of the eye and adnexa and for a duration not exceeding 42 days
β-Adrenergic blocking agents (topical)
betaxolol
levobunolol
timolol
Carbonic anhydrase inhibitors (topical)
brinzolamide
dorzolamide
Miotics (topical)
carbachol
pilocarpine
Prostaglandin analogs (topical)
bimatoprost
latanoprost
tafluprost
travoprost
α-Adrenergic agonists (topical)
apraclonidine
brimonidine
α-Adrenergic agonists/β-adrenergic blocking agents (topical)
brimonidine/timolol
Carbonic anhydrase inhibitors/β-adrenergic blocking agents (topical)
brinzolamide/timolol
dorzolamide/timolol
Prostaglandin analogs/β-adrenergic blocking agents (topical)
latanoprost/timolol
travoprost/timolol
Carbonic anhydrase inhibitors (oral) – to lower intraocular pressure only and a member shall immediately refer the patient to a physician or to a hospital
acetazolamide
Secretagogues (oral) – for Sjögren’s syndrome only and only in collaboration with a physician with whom the member has established a co-management model of care
pilocarpine